Started in 1999, was established by sisters Randi and Kimberly Holland. Kimberly was diagnosed in March 1994 at the age of 24 with Stage IIB Hodgkin's Disease. It is dedicated to creating an awareness of a disease which sometimes goes overlooked due to its 85% survival rate. Over the past 24 years, Kimberly has undergone a bone marrow transplant, a stem cell transplant, and numerous chemotherapy and radiation treatments since she was diagnosed, but has not responded to traditional chemotherapy. After numerous experimental treatments, after her thirteenth clinical trial on Nivolumab(Opdivo), which started as a trial and is now FDA approved. Our goal is to create as much forward progress as possible to continue to open the doors to clinical trials in the future that may save lives.